Astria Therapeutics
ATXS
ATXS
115 hedge funds and large institutions have $311M invested in Astria Therapeutics in 2025 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 36
40% less capital invested
Capital invested by funds: $523M → $311M (-$212M)
86% less call options, than puts
Call options by funds: $5K | Put options by funds: $36K
Holders
115
Holding in Top 10
1
Calls
$5K
Puts
$36K
Top Buyers
| 1 | +$5.07M | |
| 2 | +$2.94M | |
| 3 | +$2.34M | |
| 4 |
Renaissance Technologies
New York
|
+$957K |
| 5 |
Jane Street
New York
|
+$442K |
Top Sellers
| 1 | -$4.74M | |
| 2 | -$2.38M | |
| 3 | -$1.55M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.16M |
| 5 |
SCM
Sio Capital Management
New York
|
-$1.01M |
